350 related articles for article (PubMed ID: 19202957)
1. Current diagnostic evaluation of autosomal dominant polycystic kidney disease.
Wołyniec W; Jankowska MM; Król E; Czarniak P; Rutkowski B
Pol Arch Med Wewn; 2008 Dec; 118(12):767-73. PubMed ID: 19202957
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
[TBL] [Abstract][Full Text] [Related]
3. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
4. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
[TBL] [Abstract][Full Text] [Related]
5. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Brosnahan GM; Abebe KZ; Moore CG; Rahbari-Oskoui FF; Bae KT; Grantham JJ; Schrier RW; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Miskulin DC; Steinman TI; Torres VE;
Am J Kidney Dis; 2018 May; 71(5):666-676. PubMed ID: 29306517
[TBL] [Abstract][Full Text] [Related]
7. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
9. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
10. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
11. Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.
Helal I; Reed B; Schrier RW
Am J Nephrol; 2012; 36(2):162-7. PubMed ID: 22846584
[TBL] [Abstract][Full Text] [Related]
12. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
[TBL] [Abstract][Full Text] [Related]
14. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
[TBL] [Abstract][Full Text] [Related]
15. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease.
Wong H; Vivian L; Weiler G; Filler G
Am J Kidney Dis; 2004 Apr; 43(4):624-8. PubMed ID: 15042539
[TBL] [Abstract][Full Text] [Related]
16. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB;
Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764
[TBL] [Abstract][Full Text] [Related]
17. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
18. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.
Sise C; Kusaka M; Wetzel LH; Winklhofer F; Cowley BD; Cook LT; Gordon M; Grantham JJ
Kidney Int; 2000 Dec; 58(6):2492-501. PubMed ID: 11115083
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
[TBL] [Abstract][Full Text] [Related]
20. Early renal abnormalities in autosomal dominant polycystic kidney disease.
Meijer E; Rook M; Tent H; Navis G; van der Jagt EJ; de Jong PE; Gansevoort RT
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1091-8. PubMed ID: 20413443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
